Literature DB >> 8626397

Purification and characterization of human cleavage factor Im involved in the 3' end processing of messenger RNA precursors.

U Rüegsegger1, K Beyer, W Keller.   

Abstract

Six different protein factors are required for the specific cleavage and polyadenylation of pre-mRNA in mammals. Whereas four of them have been purified and most of their components cloned, cleavage factor Im (CF Im) and cleavage factor IIm (CF IIm) remained poorly characterized. We report here the separation of CF Im from CF 11m and the purification of CF Im to near homogeneity. Three polypeptides of 68, 59, and 25 kDa copurify with CF Im activity. All three polypeptides can be UV cross-linked to a cleavage and polyadenylation substrate in the presence of a large excess of unspecific competitor RNA, but not to a splicing-only substrate. No additional protein factor is required for the binding of CF Im to pre-mRNA. Gel retardation experiments confirmed the results obtained by UV cross-linking. In addition, we could show that CF Im stabilizes the binding of the cleavage and polyadenylation specificity factor (CPSF) to pre-mRNA and that CPSF and CF Im together form a slower migrating complex with pre-mRNA than the single protein factors. Cleavage stimulation factor (CstF) and poly(A) polymerase (PAP) had no detectable effect on the binding of CF Im to pre-mRNA. Furthermore, the CstF-CPSF-RNA as well as the CstF-CPSF-PAP-RNA complex are supershifted and stabilized upon the addition of CF Im.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8626397     DOI: 10.1074/jbc.271.11.6107

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  84 in total

1.  Recruitment of a basal polyadenylation factor by the upstream sequence element of the human lamin B2 polyadenylation signal.

Authors:  S Brackenridge; N J Proudfoot
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

2.  Isolation and characterization of polyadenylation complexes assembled in vitro.

Authors:  K L Veraldi; G Edwalds-Gilbert; C C MacDonald; A M Wallace; C Milcarek
Journal:  RNA       Date:  2000-05       Impact factor: 4.942

3.  Position-dependent inhibition of the cleavage step of pre-mRNA 3'-end processing by U1 snRNP.

Authors:  S Vagner; U Rüegsegger; S I Gunderson; W Keller; I W Mattaj
Journal:  RNA       Date:  2000-02       Impact factor: 4.942

Review 4.  Formation of mRNA 3' ends in eukaryotes: mechanism, regulation, and interrelationships with other steps in mRNA synthesis.

Authors:  J Zhao; L Hyman; C Moore
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

5.  Association of polyadenylation cleavage factor I with U1 snRNP.

Authors:  Sita Awasthi; James C Alwine
Journal:  RNA       Date:  2003-11       Impact factor: 4.942

6.  The poly A polymerase Star-PAP controls 3'-end cleavage by promoting CPSF interaction and specificity toward the pre-mRNA.

Authors:  Rakesh S Laishram; Richard A Anderson
Journal:  EMBO J       Date:  2010-11-19       Impact factor: 11.598

Review 7.  Pre-mRNA 3'-end processing complex assembly and function.

Authors:  Serena Chan; Eun-A Choi; Yongsheng Shi
Journal:  Wiley Interdiscip Rev RNA       Date:  2010-10-18       Impact factor: 9.957

8.  Exploring Modifications of an HIV-1 Capsid Inhibitor: Design, Synthesis, and Mechanism of Action.

Authors:  Jimmy P Xu; Ashwanth C Francis; Megan E Meuser; Marie Mankowski; Roger G Ptak; Adel A Rashad; Gregory B Melikyan; Simon Cocklin
Journal:  J Drug Des Res       Date:  2018-08-13

9.  Analysis of a noncanonical poly(A) site reveals a tripartite mechanism for vertebrate poly(A) site recognition.

Authors:  Krishnan Venkataraman; Kirk M Brown; Gregory M Gilmartin
Journal:  Genes Dev       Date:  2005-06-01       Impact factor: 11.361

10.  The upstream sequence element of the C2 complement poly(A) signal activates mRNA 3' end formation by two distinct mechanisms.

Authors:  A Moreira; Y Takagaki; S Brackenridge; M Wollerton; J L Manley; N J Proudfoot
Journal:  Genes Dev       Date:  1998-08-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.